Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890187 · ClinicalTrials.gov registry record
Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium
A clinical trial of Advanced Dry AMD With Geographic Atrophy, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- 85
- Enrollment target
- 1
- Study location
NCT01890187: Completed study of Advanced Dry AMD With Geographic Atrophy, sponsored by Carl Zeiss Meditec.
NCT01890187 is a study of Advanced Dry AMD With Geographic Atrophy that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 85 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01890187, a study of Advanced Dry AMD With Geographic Atrophy, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the repeatability and reproducibility of the Cirrus HD-OCT measurement of illumination areas under the retinal pigment epithelium (RPE).
Conditions Studied
Study Locations (1)
California
- West Coast Retina - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-02 |
What the finished NCT01890187 record still lists
NCT01890187 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 1 condition, with Advanced Dry AMD With Geographic Atrophy appearing as the primary indexed condition, and to 0 interventions.
NCT01890187 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01890187 about?
NCT01890187 is a clinical study titled "Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium". The objective of this study is to determine the repeatability and reproducibility of the Cirrus HD-OCT measurement of illumination areas under the retinal pigment epithelium (RPE).
What is the current status of trial NCT01890187?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2010-11. Estimated completion is 2011-02.
What conditions does trial NCT01890187 study?
This clinical trial studies the following conditions: Advanced Dry AMD With Geographic Atrophy.
Who is sponsoring clinical trial NCT01890187?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01890187 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia